155 related articles for article (PubMed ID: 18993078)
41. [Synthesis of lipophilic keto acids by acylation of alkylbenzenes as potential inhibitors of phospholipase A2].
Nuhn P; Radman M; Hermann A; Marx K
Pharmazie; 1998 Dec; 53(12):825-9. PubMed ID: 10189306
[No Abstract] [Full Text] [Related]
42. Systemic and intrathecal effects of a novel series of phospholipase A2 inhibitors on hyperalgesia and spinal prostaglandin E2 release.
Yaksh TL; Kokotos G; Svensson CI; Stephens D; Kokotos CG; Fitzsimmons B; Hadjipavlou-Litina D; Hua XY; Dennis EA
J Pharmacol Exp Ther; 2006 Jan; 316(1):466-75. PubMed ID: 16203828
[TBL] [Abstract][Full Text] [Related]
43. D-Tyrosine as a chiral precusor to potent inhibitors of human nonpancreatic secretory phospholipase A2 (IIa) with antiinflammatory activity.
Hansford KA; Reid RC; Clark CI; Tyndall JD; Whitehouse MW; Guthrie T; McGeary RP; Schafer K; Martin JL; Fairlie DP
Chembiochem; 2003 Mar; 4(2-3):181-5. PubMed ID: 12616631
[TBL] [Abstract][Full Text] [Related]
44. Inhibition of secretory phospholipase A2. 1-design, synthesis and structure-activity relationship studies starting from 4-tetradecyloxybenzamidine to obtain specific inhibitors of group II sPLA2s.
Assogba L; Ahamada-Himidi A; Habich NM; Aoun D; Boukli L; Massicot F; Mounier CM; Huet J; Lamouri A; Ombetta JE; Godfroid JJ; Dong CZ; Heymans F
Eur J Med Chem; 2005 Sep; 40(9):850-61. PubMed ID: 16084626
[TBL] [Abstract][Full Text] [Related]
45. Location of inhibitors bound to group IVA phospholipase A2 determined by molecular dynamics and deuterium exchange mass spectrometry.
Burke JE; Babakhani A; Gorfe AA; Kokotos G; Li S; Woods VL; McCammon JA; Dennis EA
J Am Chem Soc; 2009 Jun; 131(23):8083-91. PubMed ID: 19459633
[TBL] [Abstract][Full Text] [Related]
46. Amides of xanthurenic acid as zinc-dependent inhibitors of Lp-PLA(2).
Lin EC; Hu Y; Amantea CM; Pham LM; Cajica J; Okerberg E; Brown HE; Fraser A; Du L; Kohno Y; Ishiyama J; Kozarich JW; Shreder KR
Bioorg Med Chem Lett; 2012 Jan; 22(2):868-71. PubMed ID: 22217870
[TBL] [Abstract][Full Text] [Related]
47. Design of new potent and selective secretory phospholipase A(2) inhibitors. 6-Synthesis, structure-activity relationships and molecular modelling of 1-substituted-4-[4,5-dihydro-1,2,4-(4H)-oxadiazol-5-one-3-yl(methyl)]-functionalized aryl piperazin/one/dione derivatives.
Meddad-Belhabich N; Aoun D; Djimdé A; Redeuilh C; Dive G; Massicot F; Chau F; Heymans F; Lamouri A
Bioorg Med Chem; 2010 May; 18(10):3588-600. PubMed ID: 20417107
[TBL] [Abstract][Full Text] [Related]
48. Design, synthesis, and evaluation of cyclic amide/imide-bearing hydroxamic acid derivatives as class-selective histone deacetylase (HDAC) inhibitors.
Shinji C; Maeda S; Imai K; Yoshida M; Hashimoto Y; Miyachi H
Bioorg Med Chem; 2006 Nov; 14(22):7625-51. PubMed ID: 16877001
[TBL] [Abstract][Full Text] [Related]
49. Design and synthesis of 1-indol-1-yl-propan-2-ones as inhibitors of human cytosolic phospholipase A2alpha.
Ludwig J; Bovens S; Brauch C; Elfringhoff AS; Lehr M
J Med Chem; 2006 Apr; 49(8):2611-20. PubMed ID: 16610804
[TBL] [Abstract][Full Text] [Related]
50. Indole inhibitors of human nonpancreatic secretory phospholipase A2. 1. Indole-3-acetamides.
Dillard RD; Bach NJ; Draheim SE; Berry DR; Carlson DG; Chirgadze NY; Clawson DK; Hartley LW; Johnson LM; Jones ND; McKinney ER; Mihelich ED; Olkowski JL; Schevitz RW; Smith AC; Snyder DW; Sommers CD; Wery JP
J Med Chem; 1996 Dec; 39(26):5119-36. PubMed ID: 9005255
[TBL] [Abstract][Full Text] [Related]
51. Structure-activity relationships of (4-acylpyrrol-2-yl)alkanoic acids as inhibitors of the cytosolic phospholipase A2: variation of the substituents in positions 1, 3, and 5.
Lehr M
J Med Chem; 1997 Oct; 40(21):3381-92. PubMed ID: 9341913
[TBL] [Abstract][Full Text] [Related]
52. Synthesis and biological evaluation of novel thiadiazole amides as potent Cdc25B and PTP1B inhibitors.
Li Y; Yu Y; Jin K; Gao L; Luo T; Sheng L; Shao X; Li J
Bioorg Med Chem Lett; 2014 Sep; 24(17):4125-8. PubMed ID: 25124112
[TBL] [Abstract][Full Text] [Related]
53. Kojic acid-tripeptide amide as a new tyrosinase inhibitor.
Noh JM; Kwak SY; Kim DH; Lee YS
Biopolymers; 2007; 88(2):300-7. PubMed ID: 17211869
[TBL] [Abstract][Full Text] [Related]
54. 1-(3-biaryloxy-2-oxopropyl)indole-5-carboxylic acids and related compounds as dual inhibitors of human cytosolic phospholipase A2α and fatty acid amide hydrolase.
Zahov S; Drews A; Hess M; Schulze Elfringhoff A; Lehr M
ChemMedChem; 2011 Mar; 6(3):544-9. PubMed ID: 21259444
[TBL] [Abstract][Full Text] [Related]
55. Expression of Ca(2+)-independent and Ca(2+)-dependent phospholipases A(2) and cyclooxygenases in human melanocytes and malignant melanoma cell lines.
Scuderi MR; Anfuso CD; Lupo G; Motta C; Romeo L; Guerra L; Cappellani A; Ragusa N; Cantarella G; Alberghina M
Biochim Biophys Acta; 2008 Oct; 1781(10):635-42. PubMed ID: 18722548
[TBL] [Abstract][Full Text] [Related]
56. Potent inhibitors of secretory phospholipase A2: synthesis and inhibitory activities of indolizine and indene derivatives.
Hagishita S; Yamada M; Shirahase K; Okada T; Murakami Y; Ito Y; Matsuura T; Wada M; Kato T; Ueno M; Chikazawa Y; Yamada K; Ono T; Teshirogi I; Ohtani M
J Med Chem; 1996 Sep; 39(19):3636-58. PubMed ID: 8809154
[TBL] [Abstract][Full Text] [Related]
57. Molecular basis of phospholipase A2 inhibition by petrosaspongiolide M.
Dal Piaz F; Casapullo A; Randazzo A; Riccio R; Pucci P; Marino G; Gomez-Paloma L
Chembiochem; 2002 Jul; 3(7):664-71. PubMed ID: 12325001
[TBL] [Abstract][Full Text] [Related]
58. A practical synthesis of Rho-Kinase inhibitor Y-27632 and fluoro derivatives and their evaluation in human pluripotent stem cells.
Paleček J; Zweigerdt R; Olmer R; Martin U; Kirschning A; Dräger G
Org Biomol Chem; 2011 Aug; 9(15):5503-10. PubMed ID: 21677986
[TBL] [Abstract][Full Text] [Related]
59. Quantitative structure-activity relationship (QSAR) analysis of a series of indole analogues as inhibitor for human group V secretory phospholipase A2.
OmPraba G; Velmurugan D
Indian J Biochem Biophys; 2006 Jun; 43(3):154-9. PubMed ID: 16967904
[TBL] [Abstract][Full Text] [Related]
60. Oncogenic action of secreted phospholipase A2 in prostate cancer.
Sved P; Scott KF; McLeod D; King NJ; Singh J; Tsatralis T; Nikolov B; Boulas J; Nallan L; Gelb MH; Sajinovic M; Graham GG; Russell PJ; Dong Q
Cancer Res; 2004 Oct; 64(19):6934-40. PubMed ID: 15466184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
